About EvoBNE

We search for proteins that conventional discovery cannot find.

EvoBNE is a computational discovery engine for unexplored protein sequence space. It uses physical structure as a search-space prior, generates candidate sequences under structural constraints, and subjects them to unusually stringent novelty and biophysical analysis.

EvoBNE is the engine. EvoBNE Atlas is the discovery library.
The problem

The search space is too large to explore directly.

A 200-residue protein has 20^200 possible sequences. No experimental program, and no brute-force computational search, can enumerate that space.

Most protein discovery therefore starts from what biology has already revealed: known sequences, homologous families, conserved domains, established folds, or recognizable motifs. Those methods are extraordinarily useful, but they naturally favor regions of sequence space connected to known biology.

EvoBNE targets a different problem: finding rare candidates that are physically constrained yet have no convincing relationship to known proteins.

The objective is not to generate more proteins. It is to extract experimentally interesting candidates from an otherwise inaccessible search space.
Why it is hard

Novelty alone is not enough.

A random sequence can be novel. That does not make it useful. A useful discovery candidate has to survive several independent questions at once.

01 / PHYSICAL PLAUSIBILITY

Can we constrain the search?

The sequence must be generated under a physical prior rather than selected arbitrarily from 20^200 possibilities.

02 / NOVELTY

Is it actually unusual?

Sequence, profile, motif and structural searches are used to look for convincing relationships to existing biological space.

03 / BEHAVIOR

What does the sequence physically look like?

Disorder, composition and molecular simulations turn a raw sequence into a measurable physical and ensemble-level profile.

How EvoBNE works

Collapse the search space. Then challenge what survives.

EvoBNE uses a structural representation as a computational anchor. Structure-conditioned sequence design then searches a constrained region of sequence space rather than attempting to enumerate sequence space directly.

1. Physical priorGenerate a physically defined structural starting point.
2. Sequence designUse structure-conditioned generation to identify compatible sequences.
3. Darkness filterChallenge candidates against known sequence, motif and structural space.
4. Disorder & physicsCharacterize sequence properties and dynamic ensemble behavior.
5. Atlas qualificationPackage the surviving candidate with its computational evidence trail.

The starting structure is a search-space compression device, not a claim that an intrinsically disordered protein possesses that single fixed structure in its biological state.

An Atlas candidate

What a qualified discovery looks like.

Candidate evo_c137 illustrates the type of computational dossier produced by the Atlas. The numbers below are taken directly from its Atlas record.

EvoBNE Atlas / Candidate

evo_c137

376 AA · 29.698 kDa · pI 7.88 · computationally qualified dark candidate

NO DETECTABLE HOMOLOGY · 0 BLAST · 0 FOLDSEEK
0.901DISORDER
Random coilENSEMBLE CLASS
5.66 nmRg ENSEMBLE MEAN
EXPANDED RANDOM COILARCHITECTURE

The candidate does not merely have a novel-looking sequence. It has an evidence trail across sequence, structure, motif and disorder analyses.

Novelty evidence
  • No detectable sequence homology
  • No structural neighbours
  • ESMFold: no confident fold
  • No known bioactive motifs
  • Reproducible simulation
Physical characterization
  • LENGTH: 376 AA
  • MOLECULAR WEIGHT: 29.698 kDa
  • ISOELECTRIC POINT: 7.88
  • NET CHARGE pH 7.4: +0.5
  • GRAVY: 0.198
  • FCR: 0.045
Hydropathy plot for evo_c137

Hydropathy profile for evo_c137. The plot is one component of the candidate's broader physical fingerprint; it is not presented as proof of a particular material function.

The customer does not receive a FASTA file and a promise. They receive a candidate and the evidence needed to decide whether it deserves an experiment.

Not claimed: allergen safety, GRAS status, immunogenicity, expression or production yield. No data package for these has been supplied yet.

From orphan to family

One dark sequence is a discovery. A dark family can be a new design space.

EvoBNE does not require broad coverage of sequence space to create value. A single strong orphan can be worth pursuing. When multiple generated candidates are related to one another but remain disconnected from known biological families, the discovery becomes more powerful.

Against known biology

Externally dark

No convincing relationship is detected in the reference sequence and structural databases searched.

Against the Atlas candidate set

Internally coherent

Related candidates can form a sequence or structural family, creating a local design landscape that did not appear in the external databases.

This creates an important discovery unit: not simply a protein, but a previously unrecognized region of protein space that can contain related candidates with different predicted physical properties.

EvoBNE Atlas

A library of computationally qualified options.

EvoBNE is the discovery engine. EvoBNE Atlas is the library of candidates that survive the process.

Sequence & provenance

Sequence, generation context, structural prior and discovery record.

Novelty dossier

Sequence, profile, motif and structural search evidence documenting the candidate's relationship, or lack of relationship, to known space.

Physical fingerprint

Disorder, charge, pI, hydropathy, composition and related sequence-derived descriptors.

Ensemble profile

Conformational statistics, Rg, contacts, scaling behavior and simulation diagnostics where applicable.

Why customers use it

Buy an option on unexplored protein space.

The value is not the cost of generating a sequence. The value is the discovery process that makes an otherwise inaccessible candidate experimentally actionable.

Customers can access qualified Atlas candidates and obtain an exclusive evaluation option for a defined period and application. The customer then decides whether the candidate deserves synthesis and experimental development.

This creates an asymmetric discovery model: a relatively small evaluation commitment can provide access to a candidate whose downstream value, if experimental validation succeeds, may be much larger.

We do not sell certainty. We sell high-quality options on unexplored protein sequence space.
EvoBNE

Find what biology has not already named.

EvoBNE turns physical priors, structure-conditioned sequence discovery, stringent novelty screening and ensemble characterization into a practical discovery system for proteins outside recognizable biological space.

EvoBNE discovers. EvoBNE Atlas qualifies. Experimental science decides what comes next.